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Perspective
Introduction
The purpose of the Perspectives in General Physiology is 
to provide a forum where scientific uncertainties or con-
troversies are discussed in an authoritative, yet open, 
manner. Perspectives are solicited by the editors—often 
based on recommendations by members of the editorial 
advisory board. The comments and opinions expressed 
in the Perspectives are those of the authors and not nec-
essarily  those  of  the  editors  or  the  editorial  advisory 
board. The Perspectives are accompanied by a few edito-
rial paragraphs that introduce the problem and followed 
by an invitation to readers to submit comments.
This Perspectives series was inspired by the 63rd Sym-
posium of the Society of General Physiologists on “Muscle 
in Health and Disease,” which was co-organized by Drs. 
H. Lee Sweeney (University of Pennsylvania) and David 
A. Eisner (University of Manchester) and held in Woods 
Hole, Massachusetts, in September 2009. The contribu-
tions  cover  key  novel  findings,  unresolved  questions, 
and clinical implications of three essential muscle pro-
cesses (excitation–contraction [EC] coupling, thin/thick 
filament regulation, and membrane stabilization dur-
ing contraction) that are each controlled by distinct 
multiprotein machines.
Historical perspective
The mechanisms that control striated muscle contraction 
have been the focus of intense research for centuries. The 
classical studies of Sydney Ringer, conducted while at the 
University College London and published in a series of 
four publications in 1882 and 1883, were the first to dem-
onstrate that extracellular Ca
2+ ions are required to main-
tain  the  normal  rate  and  contractile  strength  of  the 
isolated frog heart. Ringer’s work, while both remarkably 
methodical and meticulous, was also surprisingly seren-
dipitous. As the often recounted legend goes, Ringer’s 
landmark discovery resulted only after realizing that his 
research assistant had prepared the heart perfusate using 
hard London tap water, complete with high levels of inor-
ganic constituents including 1 mM Ca
2+! Subsequent 
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experiments using distilled water blocked contractions, 
and  the  re-addition  of  appropriate  levels  of  NaCl, 
NaHCO3, KCl, and, of course, CaCl2 to the distilled water 
were required to enable the heart to “continue beating 
perfectly.” Thus was launched the field of ion homeostasis 
and its role in the control of normal muscle physiology 
and disease.
Subsequent seminal work in muscle physiology over 
the last 100 years includes, among others, the character-
ization of heat production and metabolism in working 
muscle by A.V. Hill in the early 1900s; the pioneering 
studies of the sliding filament theory of A.F. Huxley and 
H.E. Huxley in the 1950s; elegant early electron micros-
copy ultrastructural studies of transverse tubules and tri-
ads in skeletal muscle fibers by C. Franzini-Armstrong in 
the 1960s; the discovery of intramembrane charge move-
ment within the transverse tubule membrane and its as-
sociation with the control of intracellular Ca
2+ release by 
W.K. Chandler and colleagues in the 1970s; and linkage 
of the dystrophin gene to Duchenne muscular dystrophy 
by L.M. Kunkel in 1986 and subsequent characterization 
of the molecular players in the dystrophin–glycoprotein 
complex by K.P. Campbell and others.
Fast forward more than 125 years from Sydney Ringer’s 
landmark studies. Leading muscle researchers across the 
world make a “pilgrimage” of sorts to the Marine Biologi-
cal Laboratory to participate in the 63rd Symposium of 
the Society of General Physiologists on “Muscle in Health 
and Disease.” Presentations and discussions at the meet-
ing, both formal and informal, focus around new find-
ings, insights, and how to address current unanswered 
questions and challenges in the field. As both active par-
ticipants and interested observers, we were struck by a 
common recurring theme throughout the conference 
that involved the use of multidisciplinary cutting-edge 
approaches to investigate the molecular mechanisms by 
which complex protein–protein interactions dictate the 
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a myosin with the head anchored to a thick filament and 
undergoing an ATP-dependent cross-bridge cycle. But 
as Solaro et al. point out, the contractile unit is the sar-
comere, a complex macromolecular machine compris-
ing not only actin, myosin, tropomyosin, and troponins, 
but also other proteins that stoichiometrically bind to 
the core components and regulate cycling. Solaro et al. 
opine that studies of the role of altered interactions be-
tween  sarcomeric  proteins  regulating  striated  muscle 
contractility  have  been  metaphorically  treated  as  the 
meddlesome, ugly stepsister of its more winsome mem-
brane ion channel and transporter siblings. This Per-
spective details a new and evolving appreciation for the 
molecular  mechanisms  by  which  these  various  sarco-
meric proteins dynamically affect the myofilaments’ re-
sponse to the changing calcium landscape during the 
cardiac contraction cycle, as exemplified by adrenergic 
modulation of the rise and maintenance of cardiac sys-
tolic  contraction.  The  Perspective  submitted  by  Moss 
and Fitzsimons focuses on both the mechanisms that un-
derlie the thin filament cooperativity of Ca
2+ activation, 
and recent evidence indicating a previously unappreci-
ated role of thick filament processes in the regulation of 
contraction and in  adrenergic stimulation of the myo-
cardium. With respect to the former, there is increasing 
evidence that cross-bridge heads are “activated” during 
muscle contraction, although the mechanism(s) under-
lying this phenomenon is not yet known. With respect to 
the latter, in concert with phosphorylation of troponin I 
(TnI), the rate of cardiac force development is increased 
by PKA-mediated phosphorylation of the thick filament 
accessory protein myosin-binding protein C (MyBP-C), 
which enhances the availability of myosin cross-bridges 
to interact with actin. Together, these two Perspectives 
highlight several unresolved issues with regard to the 
sarcomeric macromolecular machine: What are the re-
spective roles of the thick and thin filament proteins in 
conferring the cooperativity of Ca
2+ activation of cross-
bridge cycling? To what degree, if any, do secondary reg-
ulatory mechanisms now well-established in the heart 
(e.g., constraint of cross-bridges by MyBP-C, phosphory-
lation of TnI or MyBP-C) impact function of the skeletal 
muscle molecular motor? How do familial hypertrophic 
and dilated cardiomyopathic missense mutations in sar-
comeric proteins trigger structural, electrical, and meta-
bolic remodeling of the heart? How can new molecular 
insights into the control and operation of the sarcomeric 
macromolecular machine be exploited to develop novel 
therapeutic agents to treat life-threatening and debilitat-
ing cardiac and skeletal muscle diseases?
The  dystrophin–glycoprotein  complex.  Goldstein  and   
McNally (University of Chicago) provide a provocative 
Perspective on the multifunctional role of the dystro-
phin–glycoprotein complex (DGC) in skeletal muscle 
and how defects of this macromolecular machine lead 
function (and dysfunction) of several highly evolved 
“macromolecular machines” in striated muscle. Empha-
sis was placed on how these macromolecular machines 
are assembled and operate to control such diverse mus-
cle functions as excitability (EC coupling mechanism), 
sarcomere shortening (thin-thick filament regulation), 
as well as lateral force transmission and sarcolemmal in-
tegrity (dystrophin–glycoprotein complex). Not surpris-
ingly,  current  work  involving  each  of  these  muscle 
macromolecular machines is strongly linked to one or 
more of the seminal studies of muscle physiology dis-
cussed above. The Perspectives in this series were selected 
to highlight progress and enduring unresolved issues in-
volving these three areas of emphasis.
Muscle macromolecular machines
The EC coupling mechanism. Beam and Bannister (Univer-
sity of Colorado) provide a comprehensive discussion of 
the current molecular understanding of the conforma-
tional coupling interaction between the dihydropyridine 
receptor (DHPR) L-type Ca
2+ channel or voltage sensor 
in the transverse tubule membrane and the type 1 RYR 
(RYR1) Ca
2+ release channel located in the terminal cis-
ternae of the sarcoplasmic reticulum. A particularly in-
triguing  aspect  of  the  DHPR–RYR1  macromolecular 
machine is that it mediates a bidirectional signaling in-
teraction between two large ion channel complexes lo-
cated in adjacent membrane compartments, with each 
channel being an assembly of multiple subunits and asso-
ciated regulatory proteins. Although the original identifi-
cation, cloning, and validation of the DHPR and RYR1 
proteins as essential players in the EC coupling process 
were demonstrated by Beam and several others in the 
late 1980s and early 1990s, the precise molecular nature 
of this intermembrane macromolecular interaction re-
mains exasperatingly enigmatic. In their Perspective, 
Beam and Bannister candidly outline the central ques-
tions regarding the DHPR–RYR1 interaction that remain 
elusive,  including:  How  is  the  ECC  signal  transmitted 
from the voltage sensor to the release channel? What are 
the respective roles of the DHPR 1S and 1a subunits? 
How is EC coupling modulated by other nonessential 
proteins  (e.g.,  FKBP12,  calmodulin,  triadin,  junctin, 
calsequestrin, etc.) associated with the DHPR–RYR1 ma-
chine? How does altered function of the EC coupling 
machine contribute to muscle disease? Like that of their 
predecessors, current and future EC coupling research-
ers will likely be driven, and even haunted, by the quest 
to provide definitive answers to these questions.
Thin-thick filament regulation of the sarcomere. The control 
of actin–myosin interactions in striated muscle is consid-
ered in two Perspectives authored by Solaro et al. (Uni-
versity of Illinois and University of Manchester) and by 
Moss and Fitzsimons (University of Wisconsin). A classi-
cal schematic of muscle force generation simply depicts   Dirksen and Pugh 5
hanced membrane stabilization using synthetic mem-
brane sealing poloxamers)?
Summary and future directions
These Perspectives manifest major shifts underway in 
understanding of the molecular mechanisms of physi-
ological processes that mediate and regulate muscle 
contraction. On the one hand, there is a shift toward 
elucidating dynamic changes in the macromolecular 
complexes  that  control  muscle  excitation,  contrac-
tion, and membrane stability, and on the other a con-
tinuing  shift  toward  deeper  characterization  of  the 
specific  molecular  interfaces  involved  in  these  pro-
tein–protein interactions. It is increasingly clear that a 
comprehensive  understanding  of  the  molecular 
mechanisms of muscle disease and the future develop-
ment  of  rational  therapies  requires  continued  ad-
vances in both directions.
Letters to the editor related to these Perspectives will 
be published in the October 2010 issue of the Journal. 
Letters to the editor should be received no later than 
Monday, August 16, 2010, to allow for editorial review. 
The letters may be no longer than two printed pages 
(approximately  six  double-spaced  pages)  and  will  be 
subject to editorial review. They may contain no more 
than one figure, no more than 15 references, and no 
significant  references  to  unpublished  work.  Letters 
should be prepared according to the Journal’s instruc-
tions and can be submitted electronically, or as an e-mail 
attachment to jgp@rockefeller.edu.
to muscular dystrophy. The DGC, concentrated within 
costameres, a cytoskeletal lattice along the plasma mem-
brane, is a multiprotein complex consisting of dystro-
phin, dystroglycan, syntrophins, actin, and numerous 
other associated proteins, including sarcoglycans, dys-
trobrevin, and nitric oxide synthase. The DGC struc-
turally couples the intracellular actin cytoskeleton to 
the extracellular matrix and mediates multiple critical 
functional roles, including: maintenance of membrane 
integrity/stiffness, lateral force transmission, and scaf-
folding  of  signaling  molecules.  Loss  of  this  complex 
in muscular dystrophy results in costamere disorgani-
zation,  increased  membrane  fragility  and  leakiness, 
muscle weakness, necrosis, as well as altered signaling 
via  Ca
2+  influx/release,  nitric  oxide,  reactive  oxygen 
species, and the extracellular matrix. Many unresolved 
issues continue to plague investigators in the field, in-
cluding: What is the relative importance of muscle fiber 
loss and muscle fiber dysfunction to muscle weakness 
that occurs in the muscular dystrophies? What is the 
relative importance of the different DGC functions 
(membrane stability, force transmission, and signaling) 
in muscle fiber loss and dysfunction? What are the most 
effective ways in restoring dystrophin expression (e.g., 
viral-mediated  gene  transfer,  oligonucleotide-directed 
exon skipping, utrophin up-regulation, and stem cell 
transplantation)? What are the most effective ways to 
limit damage due to loss of DGC function (e.g., inhibi-
tion of stretch-activated Ca
2+ influx, RYR stabilization,   
TGF- inhibition, augmented NO signaling, and en-